Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of the Safety and Efficacy of the Felix NeuroAI Wristband in Essential Tremor

NCT: NCT06235190 · COMPLETED

NCT IDNCT06235190
StatusCOMPLETED
Start Date2024-02-27
Completion2025-11-06
SponsorFasikl Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this clinical study is to compare Felix NeuroAI Wristband and sham device in patients with essential tremor. The main question it aims to answer is: • Is Felix a safe and efficacious treatment for patients with essential tremor? Participants will be treated with either Felix or Sham for a period of up to 90 days. After that, they will be eligible to participate in a long-term, open-label study and be treated with Felix.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑